antihemophilic factor (b-domain deleted recombinant) FC fusion protein 1 UNT Injection

RxCUI: 1719608
RxNorm name: antihemophilic factor (b-domain deleted recombinant) FC fusion protein 1 UNT Injection
Display name: antihemophilic factor (b-domain deleted recombinant) FC fusion protein 1 UNT Injection
Full name: antihemophilic factor (b-domain deleted recombinant) FC fusion protein 1 UNT Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:24

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125487	Eloctate	Antihemophilic Factor (Recombinant), Fc Fusion protein	351(a)	Rx	2026-09-01

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Adverse event summaries are temporarily unavailable. Other product information remains available.

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
e1419c33-ef07-4268-be1f-c8993502d597	factor VIII (b-domain deleted recombinant) FC fusion protein 1 UNT Injection [PSN] · efmoroctocog alfa 1 UNT Injection [SCD] · antihemophilic factor (b-domain deleted recombinant) FC fusion protein 1 UNT Injection [SY]	3	10	These highlights do not include all the information needed to use ELOCTATE ® safely and effectively. See full prescribing information for ELOCTATE. ELOCTATE ® [Antihemophilic factor (recombinant), Fc fusion protein], Lyophilized powder for solution for intravenous injection Initial U.S. Approval: 2014	20230505